Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.29
+0.06 (0.83%)
At close: Feb 27, 2026, 4:00 PM EST
7.28
-0.01 (-0.14%)
After-hours: Feb 27, 2026, 7:14 PM EST
Organon & Co. Stock Forecast
Stock Price Forecast
The 4 analysts that cover Organon & Co. stock have a consensus rating of "Hold" and an average price target of $11.75, which forecasts a 61.18% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $18.
Price Target: $11.75 (+61.18%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Organon & Co. stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $7.5 → $8 | Sell | Maintains | $7.5 → $8 | +9.74% | Feb 24, 2026 |
| Barclays | Barclays | Sell Initiates $7.5 | Sell | Initiates | $7.5 | +2.88% | Dec 9, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $14 → $12 | Sell | Maintains | $14 → $12 | +64.61% | Nov 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +23.46% | Nov 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $24 → $18 | Buy | Maintains | $24 → $18 | +146.91% | May 15, 2025 |
Financial Forecast
Revenue This Year
6.18B
from 6.22B
Decreased by -0.64%
Revenue Next Year
6.28B
from 6.18B
Increased by 1.65%
EPS This Year
3.87
from 0.72
Increased by 438.06%
EPS Next Year
4.05
from 3.87
Increased by 4.41%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.5B | 6.8B | |||
| Avg | 6.2B | 6.3B | |||
| Low | 5.8B | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.8% | 9.5% | |||
| Avg | -0.6% | 1.7% | |||
| Low | -6.4% | -6.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.21 | 4.36 | |||
| Avg | 3.87 | 4.05 | |||
| Low | 3.48 | 3.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 484.8% | 12.5% | |||
| Avg | 438.1% | 4.4% | |||
| Low | 383.2% | -4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.